Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.


Project Scope 

The scope of this project is to identify a primary and backup representative for each PHUSE regulatory referenced deliverable that will:

  • Review updates to regulatory documents where PHUSE deliverables are referenced to ensure they are in alignment
  • Identify any updates that are required due to updated regulatory documents
  • Organise the updates, including addressing feedback from PHUSE members
  • Discuss the updates with the ODS Working Group leads to agree on the updates
  • Oversee the updates and publishing of PHUSE deliverables

The project team will discuss how often the updates should occur to avoid burdening the project team members and also regulatory authorities in reviewing the updated deliverables.


Project Statement 

The Optimizing the Use of Data Standards Working Group is responsible for the maintenance of three Regulatory Referenced Deliverables and three that will be published in the future. There is no regular maintenance process for updating these deliverables due to updates to binding and non-binding guidance from regulatory authorities. The project teams that were formed to create the documents no longer meet on a regular basis. This project will address the issue of implementing scheduled updates to these deliverables. It is important to be in compliance with the guidances from regulatory authorities. 


Project Impact 
Regulatory authorities reference the deliverables within their guidance documents. The deliverables must be in alignment with the guidance documents. Stakeholders include regulatory authorities and organisations that create the regulatory referenced deliverables. FDA expects sponsors to submit the deliverables utilising the templates that PHUSE creates. Included in the PHUSE deliverables are the templates, example documents, and completion guidelines.


Project Leads Email 

Jane Lozano , (Eli Lilly)

lozano_jane_a@lilly.com 

Janet Low , Merk (Merk)

janet_low@merck.com


Status
colourBlue
titleCurrent Status
Q2/3 2022

Project approved Q3 2022.